94.06
                                            Schlusskurs vom Vortag:
              $90.60
            Offen:
              $90.52
            24-Stunden-Volumen:
                344.88K
            Relative Volume:
              0.73
            Marktkapitalisierung:
                $2.04B
            Einnahmen:
              $747.40M
            Nettoeinkommen (Verlust:
              $-12.60M
            KGV:
              -122.36
            EPS:
                -0.7687
            Netto-Cashflow:
                $105.18M
            1W Leistung:
              +1.29%
            1M Leistung:
              +4.93%
            6M Leistung:
                +28.94%
            1J Leistung:
              +61.64%
            Ani Pharmaceuticals Inc Stock (ANIP) Company Profile
Firmenname
                  
                      Ani Pharmaceuticals Inc
                    
                Sektor
                  Telefon
                  
                      (218) 634-3500
                    
                Adresse
                  
                      210 MAIN STREET WEST, BAUDETTE, MN
                    
                Vergleichen Sie ANIP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                ANIP
                            
                             
                        Ani Pharmaceuticals Inc 
                           | 
                    94.06 | 2.02B | 747.40M | -12.60M | 105.18M | -0.7687 | 
| 
                         
                          
                                ZTS
                            
                             
                        Zoetis Inc 
                           | 
                    144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 | 
| 
                         
                          
                                TAK
                            
                             
                        Takeda Pharmaceutical Co Adr 
                           | 
                    13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 | 
| 
                         
                          
                                HLN
                            
                             
                        Haleon Plc Adr 
                           | 
                    9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 | 
| 
                         
                          
                                TEVA
                            
                             
                        Teva Pharmaceutical Industries Ltd Adr 
                           | 
                    20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 | 
| 
                         
                          
                                UTHR
                            
                             
                        United Therapeutics Corp 
                           | 
                    438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 | 
Ani Pharmaceuticals Inc Stock (ANIP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung | 
|---|---|---|---|
| 2025-07-10 | Eingeleitet | H.C. Wainwright | Buy | 
| 2025-03-14 | Eingeleitet | Jefferies | Buy | 
| 2025-03-12 | Eingeleitet | JP Morgan | Overweight | 
| 2024-12-11 | Eingeleitet | Leerink Partners | Outperform | 
| 2024-10-11 | Eingeleitet | Piper Sandler | Overweight | 
| 2024-03-15 | Eingeleitet | CapitalOne | Overweight | 
| 2023-08-22 | Bestätigt | H.C. Wainwright | Buy | 
| 2023-03-01 | Eingeleitet | Guggenheim | Buy | 
| 2022-09-07 | Eingeleitet | H.C. Wainwright | Buy | 
| 2021-11-02 | Eingeleitet | Truist | Buy | 
| 2020-05-07 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral | 
| 2019-09-12 | Eingeleitet | Guggenheim | Buy | 
| 2019-05-10 | Herabstufung | Raymond James | Strong Buy → Outperform | 
| 2017-10-16 | Bestätigt | Canaccord Genuity | Buy | 
| 2017-07-31 | Eingeleitet | Canaccord Genuity | Buy | 
| 2017-02-22 | Herabstufung | ROTH Capital | Buy → Neutral | 
| 2016-06-23 | Eingeleitet | Raymond James | Strong Buy | 
| 2016-05-24 | Herabstufung | Standpoint Research | Buy → Hold | 
| 2015-11-13 | Eingeleitet | Standpoint Research | Buy | 
| 2015-09-28 | Hochstufung | ROTH Capital | Neutral → Buy | 
| 2015-08-05 | Bestätigt | Oppenheimer | Outperform | 
| 2015-08-04 | Bestätigt | ROTH Capital | Neutral | 
| 2015-07-31 | Bestätigt | Oppenheimer | Outperform | 
| 2015-07-15 | Bestätigt | ROTH Capital | Neutral | 
| 2015-06-23 | Bestätigt | Oppenheimer | Outperform | 
| 2015-05-18 | Bestätigt | ROTH Capital | Neutral | 
| 2015-05-06 | Bestätigt | Oppenheimer | Outperform | 
| 2015-04-10 | Herabstufung | ROTH Capital | Buy → Neutral | 
| 2015-02-26 | Bestätigt | ROTH Capital | Buy | 
| 2015-02-18 | Bestätigt | Oppenheimer | Outperform | 
                    Alle ansehen
                    
                  
                Ani Pharmaceuticals Inc Aktie (ANIP) Neueste Nachrichten
Smart tools for monitoring ANI Pharmaceuticals Inc.’s price actionWeekly Trend Summary & Fast Entry High Yield Stock Tips - newser.com
Why ANI Pharmaceuticals Inc. (BSFA) stock is a strong buy callGlobal Markets & Detailed Earnings Play Alerts - newser.com
What insider trading reveals about ANI Pharmaceuticals Inc. stockQuarterly Trade Review & High Conviction Buy Zone Alerts - newser.com
Will ANI Pharmaceuticals Inc. (BSFA) stock boost dividends further2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com
Can ANI Pharmaceuticals Inc. stock continue upward trendWeekly Risk Summary & Smart Allocation Stock Reports - newser.com
Using flow based indicators on ANI Pharmaceuticals Inc.2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com
ANI Pharmaceuticals (ANIP): Evaluating Valuation After Strong 2024 Share Price Gains - Yahoo Finance
Applying Elliott Wave Theory to ANI Pharmaceuticals Inc.Market Risk Report & Real-Time Volume Trigger Notifications - newser.com
Is ANI Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Summary & Weekly Stock Performance Updates - newser.com
Is ANI Pharmaceuticals Inc. stock cheap at current valuation2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
Predicting ANI Pharmaceuticals Inc. trend using moving averagesQuarterly Risk Review & Technical Entry and Exit Tips - newser.com
What indicators show strength in ANI Pharmaceuticals Inc.Weekly Investment Report & Long-Term Safe Return Strategies - newser.com
ANI Pharmaceuticals (NASDAQ:ANIP) Has A Somewhat Strained Balance Sheet - 富途牛牛
Why ANI Pharmaceuticals Inc. stock could rally in 2025Weekly Stock Summary & Safe Entry Zone Identification - newser.com
Published on: 2025-11-01 04:07:10 - newser.com
ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Published on: 2025-10-31 04:42:45 - newser.com
Published on: 2025-10-31 04:40:15 - newser.com
How ANI Pharmaceuticals Inc. stock trades during market volatility2025 Investor Takeaways & Risk Controlled Stock Pick Alerts - newser.com
Regression analysis insights on ANI Pharmaceuticals Inc. performanceWeekly Market Report & Safe Entry Point Alerts - newser.com
ANI Pharmaceuticals (ANIP) to Release Earnings on Friday - MarketBeat
ANI Pharmaceuticals, Inc. (ANIP) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Reversal indicators forming on ANI Pharmaceuticals Inc. stockExit Point & Intraday High Probability Setup Alerts - newser.com
ANI Pharmaceuticals, Inc. $ANIP Shares Purchased by Teacher Retirement System of Texas - MarketBeat
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
ANI Pharma wins Overweight rating at J.P. Morgan on growth prospects - MSN
Mizuho Markets Americas LLC Buys 15,357 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
What high frequency data says about ANI Pharmaceuticals Inc.Weekly Investment Report & Fast Moving Trade Plans - newser.com
ANI Pharmaceuticals Inc Stock Analysis and ForecastMarket Rumors and News & Trade Like a Pro Using AI Edge - earlytimes.in
ANI Pharmaceuticals: Strong Buy On Rare Disease Growth, Record Of Beating Estimates - Seeking Alpha
What dividend safety score for ANI Pharmaceuticals Inc. stockTrade Performance Summary & Low Risk High Win Rate Picks - Fundação Cultural do Pará
Will ANI Pharmaceuticals Inc. stock benefit from automationEarnings Growth Report & Weekly High Potential Stock Alerts - fcp.pa.gov.br
Will ANI Pharmaceuticals Inc. stock maintain growth storyJuly 2025 PostEarnings & High Win Rate Trade Tips - Fundação Cultural do Pará
Has ANI Pharmaceuticals (ANIP) Outpaced Other Medical Stocks This Year? - sharewise.com
Finanzdaten der Ani Pharmaceuticals Inc-Aktie (ANIP)
Umsatz
Nettogewinn
Free Cashflow
ENV
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):